Skip to main content
All lobbying filings

BLUEBIRD STRATEGIES

Lobbying for ATA ACTION · Trade association focused on ensuring access to telehealth & remote delivery of healthcar

 Filing 4th Quarter - Termination Amendment
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 21, 2026
Income
$10,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Representation ended
Dec 31, 2025
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
  • HR 3288
    Access to Prescription Digital Therapeutics Act of 2025
  • S 1702
    Access to Prescription Digital Therapeutics Act of 2025
 Lobbying activity 1
Health Issues

Access to Prescription Digital Therapeutics Act of 2025 (H.R.3288/S. 1702)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem